Genetic variation usually prevalent in Black individuals increases risk of heart failure: JAMA Medical Dialogues Editorial Team21 April 2022 9:00 AM ISTBirmingham: A new study published in the Journal of American Medical Association (JAMA) states that being a carrier of the TTR Val122Ile...
Intellia Therapeutics' NTLA-2001 to treat transthyretin amyloidosis granted orphan drug status by USFDA Ruchika Sharma24 Oct 2021 10:00 AM ISTCambridge: Intellia Therapeutics, Inc., has recently announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to...
Pfizer Tafamidis to be sold on prescription of cardiologist only: CDSCO panel Medical Dialogues Team10 Aug 2021 5:24 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Low plasma transthyretin risk factor for incident Heart Failure: JAMA MD Bureau2 Feb 2021 7:45 PM ISTTransthyretin is one of several proteins that can cause amyloidosis, a postsecretory protein folding disorder. Low...
